SCHEMBL17201738

SCHEMBL17201738

COc1cc(C=Cc2cc(O)cc(OCc3ccccc3)c2)ccc1OCc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.67
CYP1A2 P05177 1/20 0.67
CYP19A1 P11511 1/20 0.67
APP P05067 8/20 0.61
HPGD P15428 4/20 0.60
ALDH1A1 P00352 3/20 0.60
KDM4E B2RXH2 3/20 0.60
HTT P42858 1/20 0.57
PTGS1 P23219 1/20 0.57
PTGS2 P35354 1/20 0.57
GSK3B P49841 1/20 0.56
HDAC3 O15379 1/20 0.56
HDAC4 P56524 1/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC7 Q8WUI4 1/20 0.56
HDAC2 Q92769 1/20 0.56
HDAC10 Q969S8 1/20 0.56
HDAC11 Q96DB2 1/20 0.56
HDAC8 Q9BY41 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13725753 1.00 CYP1A1 (0.67) CYP1A1CYP1A2CYP19A1APPHPGD
SCHEMBL17201746 0.95 APP (0.61) CYP1A1CYP1A2CYP19A1APPHPGD
SCHEMBL17201728 0.95 CYP1A1 (0.67) CYP1A1CYP1A2CYP19A1APPHPGD
SCHEMBL17201748 0.95 APP (0.61) CYP1A1CYP1A2CYP19A1APPHPGD
SCHEMBL17201727 0.95 CYP1A1 (0.67) CYP1A1CYP1A2CYP19A1APPHPGD
SCHEMBL28440296 0.94 APP (0.61) CYP1A1CYP1A2CYP19A1APPHPGD
SCHEMBL28440910 0.88 PDCD1 (0.60) CYP1A1CYP1A2CYP19A1APPALDH1A1
SCHEMBL19734612 0.88 APP (0.70) CYP1A1CYP1A2APPHPGDALDH1A1
SCHEMBL13727654 0.86 APP (0.54) CYP1A1CYP1A2CYP19A1APPHPGD
SCHEMBL17201731 0.86 APP (0.60) APPHPGDALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634375-B2 Prenylated hydroxystilbenes Kynan Duke IP, LLC (US) 2023-04-25 US disclosed
US-20220380285-A1 PRENYLATED HYDROXYSTILBENES Kynan Duke IP, LLC (US) 2022-12-01 US disclosed
US-11352310-B2 Prenylated hydroxystilbenes Kynan Duke IP, LLC (US) 2022-06-07 US disclosed
EP-2709975-B1 PRENYLATED HYDROXYSTILBENES KYNAN DUKE IP LLC (US) 2022-01-12 EP disclosed
US-20200331833-A1 PRENYLATED HYDROXYSTILBENES THE UNIVERSITY OF SYDNEY (AU) 2020-10-22 US disclosed
US-10696615-B2 Prenylated hydroxystilbenes THE UNIVERSITY OF SYDNEY (AU) 2020-06-30 US disclosed
US-20190194105-A1 PRENYLATED HYDROXYSTILBENES THE UNIVERSITY OF SYDNEY (AU) 2019-06-27 US disclosed
US-10196335-B2 Prenylated hydroxystilbenes THE UNIVERSITY OF SYDNEY (AU) 2019-02-05 US disclosed
US-20150307429-A1 PRENYLATED HYDROXYSTILBENES Kynan Duke IP, LLC 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196335-B2 Prenylated hydroxystilbenes HMGB2, CYP51A1, CYP8B1 CYP1A1 525/4885CYP1A2 415/4885CYP19A1 212/4885
US-20200331833-A1 PRENYLATED HYDROXYSTILBENES HSD11B1, HSD3B1, CYP8B1 CYP1A1 142/4885CYP1A2 146/4885CYP19A1 64/4885
US-20220380285-A1 PRENYLATED HYDROXYSTILBENES HSD11B1, HSD3B1, CYP8B1 CYP1A1 142/4885CYP1A2 146/4885CYP19A1 64/4885
US-20150307429-A1 PRENYLATED HYDROXYSTILBENES HMGB2, CYP51A1, CYP8B1 CYP1A1 525/4885CYP1A2 415/4885CYP19A1 212/4885
US-10696615-B2 Prenylated hydroxystilbenes HSD11B1, CYP8B1, NR1H2 CYP1A1 73/4885CYP1A2 105/4885CYP19A1 79/4885
US-11352310-B2 Prenylated hydroxystilbenes HSD11B1, HSD3B1, CYP8B1 CYP1A1 142/4885CYP1A2 146/4885CYP19A1 64/4885
US-20190194105-A1 PRENYLATED HYDROXYSTILBENES HSD11B1, CYP8B1, NR1H2 CYP1A1 73/4885CYP1A2 105/4885CYP19A1 79/4885
US-11634375-B2 Prenylated hydroxystilbenes HCLS1, IWS1, UTS2R CYP1A1 1293/4885CYP1A2 1275/4885CYP19A1 1298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.